Aptevo Therapeutics Inc. (APVO)
Nasdaq: APVO · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 2016
Filings
451 filings since 2017 beside 234 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 45 days after the quarter ended. The proxy statement was last filed Aug 31, 2026.
Filings a yearinsider forms included
73635849668812263
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 1 time in the last 36 months, the newest Feb 3, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Jun 23, 2025.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest May 22, 2025.SEC letters: 26 in the last 36 months, the newest Aug 31, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Nov 11, 2026
Oct 23, 2026
8-K items 1.01, 3.03, 9.01
Major agreement signed; Change to shareholders' rights · Current report
Aug 13, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Aug 12, 2026
Jun 30, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jun 29, 2026
May 27, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
May 25, 2026
40 of 451 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.